Patrik Hesselius

1.2k total citations
43 papers, 753 citations indexed

About

Patrik Hesselius is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Patrik Hesselius has authored 43 papers receiving a total of 753 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 15 papers in Oncology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Patrik Hesselius's work include Angiogenesis and VEGF in Cancer (7 papers), Esophageal Cancer Research and Treatment (5 papers) and Cancer-related Molecular Pathways (5 papers). Patrik Hesselius is often cited by papers focused on Angiogenesis and VEGF in Cancer (7 papers), Esophageal Cancer Research and Treatment (5 papers) and Cancer-related Molecular Pathways (5 papers). Patrik Hesselius collaborates with scholars based in Sweden and Germany. Patrik Hesselius's co-authors include Gunnar Wagenius, Daniel Brattström, Michael Bergqvist, Ola Brodin, Per Johansson, Stefan Bergström, Anders Larsson, Mattias Bergqvist, J. Peter Nilsson and Alkwin Wanders and has published in prestigious journals such as British Journal of Cancer, BMC Cancer and Lung Cancer.

In The Last Decade

Patrik Hesselius

42 papers receiving 721 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrik Hesselius Sweden 16 331 238 160 125 115 43 753
Astrid Bosma Netherlands 16 625 1.9× 440 1.8× 151 0.9× 224 1.8× 180 1.6× 38 1.2k
Peter Diamond Australia 20 616 1.9× 409 1.7× 73 0.5× 170 1.4× 99 0.9× 38 1.3k
W. Andy Knight Canada 14 148 0.4× 391 1.6× 237 1.5× 70 0.6× 209 1.8× 65 1.0k
Jack Legler United States 8 201 0.6× 531 2.2× 715 4.5× 124 1.0× 165 1.4× 15 1.3k
Daniel Fridman Canada 11 126 0.4× 732 3.1× 412 2.6× 94 0.8× 99 0.9× 18 1.1k
Paula Kim United States 9 164 0.5× 221 0.9× 135 0.8× 157 1.3× 63 0.5× 12 622
Teresa Morris United Kingdom 20 256 0.8× 409 1.7× 115 0.7× 257 2.1× 265 2.3× 36 979
Mark Napier United Kingdom 16 260 0.8× 287 1.2× 117 0.7× 40 0.3× 60 0.5× 46 962
Jim Doherty United States 14 81 0.2× 262 1.1× 181 1.1× 70 0.6× 35 0.3× 37 672
Andrea Piga Italy 19 207 0.6× 258 1.1× 130 0.8× 121 1.0× 83 0.7× 35 792

Countries citing papers authored by Patrik Hesselius

Since Specialization
Citations

This map shows the geographic impact of Patrik Hesselius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrik Hesselius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrik Hesselius more than expected).

Fields of papers citing papers by Patrik Hesselius

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrik Hesselius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrik Hesselius. The network helps show where Patrik Hesselius may publish in the future.

Co-authorship network of co-authors of Patrik Hesselius

This figure shows the co-authorship network connecting the top 25 collaborators of Patrik Hesselius. A scholar is included among the top collaborators of Patrik Hesselius based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrik Hesselius. Patrik Hesselius is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Engström, Per, Patrik Hesselius, & Bertil Holmlund. (2012). Vacancy Referrals, Job Search, and the Duration of Unemployment: A Randomized Experiment. Labour. 26(4). 419–435. 13 indexed citations
2.
Wu, Xuping, Håkan Hedman, Michael Bergqvist, et al.. (2011). Expression of EGFR and LRIG proteins in oesophageal carcinoma with emphasis on patient survival and cellular chemosensitivity. Acta Oncologica. 51(1). 69–76. 17 indexed citations
3.
Hesselius, Patrik, Per Johansson, & Peter Nilsson. (2009). Sick of Your Colleagues' Absence?. SSRN Electronic Journal. 3 indexed citations
4.
Wu, Xuping, Alkwin Wanders, Lars Gedda, et al.. (2009). Hsp90 is expressed and represents a therapeutic target in human oesophageal cancer using the inhibitor 17-allylamino-17-demethoxygeldanamycin. British Journal of Cancer. 100(2). 334–343. 49 indexed citations
5.
Wagenius, Gunnar, Anders Larsson, Daniel Brattström, et al.. (2007). The role of circulating angiogenic factors in patients operated on for localized malignant melanoma.. PubMed. 27(5A). 3211–7. 8 indexed citations
6.
Eriksson, Peter, Daniel Brattström, Patrik Hesselius, et al.. (2006). Role of circulating cytokeratin fragments and angiogenic factors in NSCLC patients stage IIIa-IIIb receiving curatively intended treatment.. PubMed. 53(4). 285–90. 8 indexed citations
7.
Engström, Per, et al.. (2006). Överutnyttjande i tillfällig föräldrapenning för vård av barn. 4 indexed citations
8.
Wanders, Alkwin, Daniel Brattström, Stefan Bergström, et al.. (2006). HER-2 overexpression (3+) in patients with squamous cell esophageal carcinoma correlates with poorer survival. Diseases of the Esophagus. 19(4). 224–231. 45 indexed citations
9.
Bergqvist, Michael, Daniel Brattström, Inger Gustavsson, et al.. (2006). High-risk human papilloma virus (HPV) and survival in patients with esophageal carcinoma: a pilot study. BMC Cancer. 6(1). 94–94. 52 indexed citations
10.
Brattström, Daniel, Gunnar Wagenius, Per Sandström, et al.. (2005). Newly developed assay measuring cytokeratins 8, 18 and 19 in serum is correlated to survival and tumor volume in patients with esophageal carcinoma. Diseases of the Esophagus. 18(5). 298–303. 11 indexed citations
11.
Wagenius, Gunnar, Stefan Bergström, Daniel Brattström, et al.. (2005). The Role of Cystatin C and the Angiogenic Cytokines VEGF and bFGF in Patients with Esophageal Carcinoma. Medical Oncology. 22(1). 29–38. 15 indexed citations
12.
Bergqvist, Michael, Daniel Brattström, Anders Larsson, et al.. (2004). The role of circulating anti-p53 antibodies in patients with advanced non-small cell lung cancer and their correlation to clinical parameters and survival. BMC Cancer. 4(1). 66–66. 17 indexed citations
13.
Brattström, Daniel, Kenneth Wester, Michael Bergqvist, et al.. (2004). HER-2, EGFR, COX-2 Expression status correlated to microvessel density and survival in resected non-small cell lung cancer. Acta Oncologica. 43(1). 80–86. 32 indexed citations
14.
Brattström, Daniel, Michael Bergqvist, Patrik Hesselius, et al.. (2003). Serum VEGF and bFGF adds prognostic information in patients with normal platelet counts when sampled before, during and after treatment for locally advanced non-small cell lung cancer. Lung Cancer. 43(1). 55–62. 39 indexed citations
15.
Bergqvist, Michael, Daniel Brattström, Kristina Lamberg, et al.. (2003). The Presence of Anti-p53 Antibodies in Sera Prior to Thoracic Surgery in Non Small Cell Lung Cancer Patients: Its Implications on Tumor Volume, Nodal Involvement, and Survival. Neoplasia. 5(4). 283–287. 12 indexed citations
16.
Brattström, Daniel, Michael Bergqvist, Patrik Hesselius, et al.. (2002). Elevated preoperative serum levels of angiogenic cytokines correlate to larger primary tumours and poorer survival in non-small cell lung cancer patients. Lung Cancer. 37(1). 57–63. 55 indexed citations
17.
Bergqvist, Ann-Sofi, Michael Bergqvist, Daniel Brattström, et al.. (2002). Serum p53 autoantibodies as prognostic marker in patients with oesophageal carcinoma.. PubMed. 21(6A). 4141–5. 16 indexed citations
18.
Bergqvist, Michael, et al.. (1999). Cytokeratin 8 and 18 fragments measured in serum and their relation to survival in patients with non-small cell lung cancer.. PubMed. 19(3A). 1833–6. 9 indexed citations
19.
Brattström, Daniel, Mattias Bergqvist, Anders Larsson, et al.. (1997). Basic fibroblast growth factor and vascular fibroblast growth factor measured in sera from patients with non-small cell lung cancer.. Tumor Biology. 18. 3 indexed citations
20.
Bergqvist, Michael, Daniel Brattström, Anders Larsson, et al.. (1997). 663 P-53 antibodies in sera from patients with non small cell lung cancer indicates better survival. Lung Cancer. 18. 169–169. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Astrid Bosma Breakdown of academic impact, for papers by Peter Diamond Breakdown of academic impact, for papers by W. Andy Knight Breakdown of academic impact, for papers by Jack Legler Breakdown of academic impact, for papers by Daniel Fridman Breakdown of academic impact, for papers by Paula Kim Breakdown of academic impact, for papers by Teresa Morris Breakdown of academic impact, for papers by Mark Napier Breakdown of academic impact, for papers by Jim Doherty Breakdown of academic impact, for papers by Andrea Piga
Rankless by CCL
2026